This article explores current research on GLP-1 medications and joint pain, helping patients and clinicians set appropriate expectations for musculoskeletal outcomes during treatment
Consuming fewer than 1,200 calories daily for women or 1,500 for men can lead to nutrient deficiencies, muscle loss, and metabolic complications
Compared to general practice, the more frequent and structured use of RDNs and MNT in these trials could be one reason why these trials demonstrated larger weight reductions than seen in real-world GLP-1 utilization for obesity
Stimulate AMPK to help you lose fat, not muscle
Are Semaglutide Drops FDA Approved For Weight Loss
Originally used for Type 2 diabetes, these medications are being repurposed for a wider range of health conditions, prompting an evolution in chronic disease treatment paradigms